nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ITGAL—hematologic cancer	0.213	0.533	CbGaD
Lovastatin—HDAC2—hematologic cancer	0.117	0.292	CbGaD
Lovastatin—HDAC2—Vorinostat—hematologic cancer	0.0753	0.198	CbGbCtD
Lovastatin—UGT1A1—hematologic cancer	0.057	0.142	CbGaD
Lovastatin—SLCO1A2—Chlorambucil—hematologic cancer	0.0144	0.0379	CbGbCtD
Lovastatin—ABCB1—hematologic cancer	0.0133	0.0333	CbGaD
Lovastatin—UGT1A1—Nilotinib—hematologic cancer	0.00967	0.0254	CbGbCtD
Lovastatin—ABCC2—Daunorubicin—hematologic cancer	0.00845	0.0222	CbGbCtD
Lovastatin—UGT2B7—Epirubicin—hematologic cancer	0.0079	0.0208	CbGbCtD
Lovastatin—UGT1A1—Irinotecan—hematologic cancer	0.00664	0.0175	CbGbCtD
Lovastatin—SLCO1A2—Prednisolone—hematologic cancer	0.00545	0.0143	CbGbCtD
Lovastatin—UGT1A1—Etoposide—hematologic cancer	0.00532	0.014	CbGbCtD
Lovastatin—SLCO1A2—Prednisone—hematologic cancer	0.00514	0.0135	CbGbCtD
Lovastatin—CYP2C9—Bexarotene—hematologic cancer	0.00484	0.0127	CbGbCtD
Lovastatin—ABCB1—Lenalidomide—hematologic cancer	0.0047	0.0124	CbGbCtD
Lovastatin—SLCO1B1—Irinotecan—hematologic cancer	0.0046	0.0121	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00452	0.0119	CbGbCtD
Lovastatin—CYP3A7—Ifosfamide—hematologic cancer	0.00452	0.0119	CbGbCtD
Lovastatin—CYP3A7—Imatinib—hematologic cancer	0.00432	0.0114	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00432	0.0114	CbGbCtD
Lovastatin—CYP2C8—Bortezomib—hematologic cancer	0.00425	0.0112	CbGbCtD
Lovastatin—CYP3A5—Daunorubicin—hematologic cancer	0.00423	0.0111	CbGbCtD
Lovastatin—CYP2D6—Lomustine—hematologic cancer	0.00411	0.0108	CbGbCtD
Lovastatin—ABCC2—Irinotecan—hematologic cancer	0.00404	0.0106	CbGbCtD
Lovastatin—CYP2C9—Idarubicin—hematologic cancer	0.00401	0.0105	CbGbCtD
Lovastatin—CYP3A5—Thalidomide—hematologic cancer	0.00385	0.0101	CbGbCtD
Lovastatin—CYP3A5—Teniposide—hematologic cancer	0.00368	0.00967	CbGbCtD
Lovastatin—CYP2D6—Idarubicin—hematologic cancer	0.00367	0.00965	CbGbCtD
Lovastatin—ABCC2—Vinblastine—hematologic cancer	0.00359	0.00945	CbGbCtD
Lovastatin—CYP2C19—Bortezomib—hematologic cancer	0.00357	0.00938	CbGbCtD
Lovastatin—ABCC2—Vincristine—hematologic cancer	0.00353	0.00929	CbGbCtD
Lovastatin—CYP3A5—Ifosfamide—hematologic cancer	0.00339	0.00892	CbGbCtD
Lovastatin—ABCC2—Cisplatin—hematologic cancer	0.00329	0.00866	CbGbCtD
Lovastatin—CYP2C8—Ifosfamide—hematologic cancer	0.00326	0.00858	CbGbCtD
Lovastatin—CYP3A5—Imatinib—hematologic cancer	0.00324	0.00852	CbGbCtD
Lovastatin—ABCC2—Etoposide—hematologic cancer	0.00324	0.00851	CbGbCtD
Lovastatin—SLCO1A2—Dexamethasone—hematologic cancer	0.00321	0.00844	CbGbCtD
Lovastatin—CYP2D6—Hydroxyurea—hematologic cancer	0.00312	0.0082	CbGbCtD
Lovastatin—CYP2C19—Thalidomide—hematologic cancer	0.00311	0.00818	CbGbCtD
Lovastatin—CYP2C9—Bortezomib—hematologic cancer	0.00297	0.0078	CbGbCtD
Lovastatin—CYP2C19—Teniposide—hematologic cancer	0.00297	0.0078	CbGbCtD
Lovastatin—CYP2C8—Nilotinib—hematologic cancer	0.00283	0.00745	CbGbCtD
Lovastatin—CYP3A4—Bexarotene—hematologic cancer	0.00281	0.0074	CbGbCtD
Lovastatin—ABCB1—Daunorubicin—hematologic cancer	0.00275	0.00724	CbGbCtD
Lovastatin—CYP2C19—Ifosfamide—hematologic cancer	0.00274	0.0072	CbGbCtD
Lovastatin—CYP2D6—Bortezomib—hematologic cancer	0.00271	0.00713	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0027	0.0071	CbGbCtD
Lovastatin—CYP3A7—Irinotecan—hematologic cancer	0.0027	0.0071	CbGbCtD
Lovastatin—ABCB1—Alitretinoin—hematologic cancer	0.0027	0.0071	CbGbCtD
Lovastatin—ABCC2—Dexamethasone—hematologic cancer	0.00266	0.007	CbGbCtD
Lovastatin—CYP3A4—Busulfan—hematologic cancer	0.00262	0.00688	CbGbCtD
Lovastatin—CYP3A4—Lomustine—hematologic cancer	0.00262	0.00688	CbGbCtD
Lovastatin—CYP2C19—Imatinib—hematologic cancer	0.00261	0.00688	CbGbCtD
Lovastatin—CYP3A5—Dasatinib—hematologic cancer	0.0026	0.00685	CbGbCtD
Lovastatin—CYP2C9—Thalidomide—hematologic cancer	0.00258	0.0068	CbGbCtD
Lovastatin—SLCO1A2—Methotrexate—hematologic cancer	0.00258	0.00679	CbGbCtD
Lovastatin—CYP2C9—Teniposide—hematologic cancer	0.00247	0.00648	CbGbCtD
Lovastatin—SLCO1B1—Methotrexate—hematologic cancer	0.00243	0.0064	CbGbCtD
Lovastatin—CYP3A7—Vincristine—hematologic cancer	0.00236	0.0062	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00236	0.0062	CbGbCtD
Lovastatin—CYP3A4—Thiotepa—hematologic cancer	0.00233	0.00613	CbGbCtD
Lovastatin—CYP2C9—Ifosfamide—hematologic cancer	0.00228	0.00598	CbGbCtD
Lovastatin—ABCC2—Doxorubicin—hematologic cancer	0.00221	0.00581	CbGbCtD
Lovastatin—CYP2C9—Imatinib—hematologic cancer	0.00217	0.00572	CbGbCtD
Lovastatin—ABCC2—Methotrexate—hematologic cancer	0.00214	0.00563	CbGbCtD
Lovastatin—ABCB1—Imatinib—hematologic cancer	0.00211	0.00555	CbGbCtD
Lovastatin—CYP3A5—Irinotecan—hematologic cancer	0.00202	0.00532	CbGbCtD
Lovastatin—CYP2D6—Imatinib—hematologic cancer	0.00199	0.00523	CbGbCtD
Lovastatin—CYP2C9—Nilotinib—hematologic cancer	0.00198	0.00519	CbGbCtD
Lovastatin—ITGAL—hematopoietic system—hematologic cancer	0.00194	0.0712	CbGeAlD
Lovastatin—ABCB1—Nilotinib—hematologic cancer	0.00192	0.00504	CbGbCtD
Lovastatin—ABCB1—Vinorelbine—hematologic cancer	0.0019	0.005	CbGbCtD
Lovastatin—CYP3A4—Methoxsalen—hematologic cancer	0.00181	0.00477	CbGbCtD
Lovastatin—CYP2D6—Nilotinib—hematologic cancer	0.00181	0.00475	CbGbCtD
Lovastatin—CYP2D6—Vinorelbine—hematologic cancer	0.00179	0.00471	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00178	0.00467	CbGbCtD
Lovastatin—CYP3A7—Dexamethasone—hematologic cancer	0.00178	0.00467	CbGbCtD
Lovastatin—CYP3A5—Vincristine—hematologic cancer	0.00177	0.00465	CbGbCtD
Lovastatin—CYP3A4—Bortezomib—hematologic cancer	0.00173	0.00454	CbGbCtD
Lovastatin—CYP2C19—Prednisone—hematologic cancer	0.00172	0.00453	CbGbCtD
Lovastatin—ABCB1—Dasatinib—hematologic cancer	0.00169	0.00446	CbGbCtD
Lovastatin—ABCB1—Mitoxantrone—hematologic cancer	0.00167	0.0044	CbGbCtD
Lovastatin—CYP3A4—Daunorubicin—hematologic cancer	0.00165	0.00434	CbGbCtD
Lovastatin—CYP3A5—Etoposide—hematologic cancer	0.00162	0.00426	CbGbCtD
Lovastatin—CYP2C8—Etoposide—hematologic cancer	0.00156	0.0041	CbGbCtD
Lovastatin—ABCB1—Betamethasone—hematologic cancer	0.00149	0.00392	CbGbCtD
Lovastatin—ABCB1—Gemcitabine—hematologic cancer	0.00148	0.00389	CbGbCtD
Lovastatin—ABCB1—Prednisolone—hematologic cancer	0.00147	0.00387	CbGbCtD
Lovastatin—CYP3A4—Cytarabine—hematologic cancer	0.00146	0.00383	CbGbCtD
Lovastatin—CYP3A4—Teniposide—hematologic cancer	0.00143	0.00377	CbGbCtD
Lovastatin—ABCB1—Prednisone—hematologic cancer	0.00139	0.00366	CbGbCtD
Lovastatin—CYP3A5—Dexamethasone—hematologic cancer	0.00133	0.00351	CbGbCtD
Lovastatin—CYP3A4—Ifosfamide—hematologic cancer	0.00132	0.00348	CbGbCtD
Lovastatin—ABCB1—Irinotecan—hematologic cancer	0.00132	0.00347	CbGbCtD
Lovastatin—ITGAL—blood—hematologic cancer	0.00128	0.0472	CbGeAlD
Lovastatin—CYP2C8—Dexamethasone—hematologic cancer	0.00128	0.00337	CbGbCtD
Lovastatin—CYP3A4—Imatinib—hematologic cancer	0.00126	0.00332	CbGbCtD
Lovastatin—ITGAL—bone marrow—hematologic cancer	0.00124	0.0456	CbGeAlD
Lovastatin—PON3—bone marrow—hematologic cancer	0.00122	0.0448	CbGeAlD
Lovastatin—CYP3A4—Ruxolitinib—hematologic cancer	0.00119	0.00313	CbGbCtD
Lovastatin—ABCB1—Vinblastine—hematologic cancer	0.00117	0.00308	CbGbCtD
Lovastatin—ABCB1—Vincristine—hematologic cancer	0.00115	0.00303	CbGbCtD
Lovastatin—CYP3A4—Nilotinib—hematologic cancer	0.00115	0.00302	CbGbCtD
Lovastatin—CYP3A4—Vinorelbine—hematologic cancer	0.00114	0.003	CbGbCtD
Lovastatin—ITGAL—lung—hematologic cancer	0.00113	0.0413	CbGeAlD
Lovastatin—CYP2C9—Cisplatin—hematologic cancer	0.00111	0.00291	CbGbCtD
Lovastatin—CYP2D6—Vinblastine—hematologic cancer	0.0011	0.0029	CbGbCtD
Lovastatin—PON3—lung—hematologic cancer	0.0011	0.0406	CbGeAlD
Lovastatin—CYP2C19—Dexamethasone—hematologic cancer	0.00108	0.00283	CbGbCtD
Lovastatin—ABCB1—Cisplatin—hematologic cancer	0.00107	0.00282	CbGbCtD
Lovastatin—ITGAL—testis—hematologic cancer	0.00106	0.039	CbGeAlD
Lovastatin—ABCB1—Etoposide—hematologic cancer	0.00106	0.00278	CbGbCtD
Lovastatin—CYP3A4—Triamcinolone—hematologic cancer	0.00104	0.00274	CbGbCtD
Lovastatin—PON3—testis—hematologic cancer	0.00104	0.0383	CbGeAlD
Lovastatin—CYP3A4—Dasatinib—hematologic cancer	0.00102	0.00267	CbGbCtD
Lovastatin—CYP3A4—Mitoxantrone—hematologic cancer	0.001	0.00264	CbGbCtD
Lovastatin—CYP2C9—Dexamethasone—hematologic cancer	0.000894	0.00235	CbGbCtD
Lovastatin—CYP3A4—Betamethasone—hematologic cancer	0.000894	0.00235	CbGbCtD
Lovastatin—CYP3A4—Prednisolone—hematologic cancer	0.000882	0.00232	CbGbCtD
Lovastatin—ABCB1—Dexamethasone—hematologic cancer	0.000868	0.00228	CbGbCtD
Lovastatin—CYP3A4—Prednisone—hematologic cancer	0.000833	0.00219	CbGbCtD
Lovastatin—CYP2D6—Dexamethasone—hematologic cancer	0.000818	0.00215	CbGbCtD
Lovastatin—UGT1A1—hematopoietic system—hematologic cancer	0.000805	0.0296	CbGeAlD
Lovastatin—CYP3A4—Irinotecan—hematologic cancer	0.000789	0.00208	CbGbCtD
Lovastatin—HDAC2—hematopoietic system—hematologic cancer	0.000775	0.0285	CbGeAlD
Lovastatin—ITGAL—lymph node—hematologic cancer	0.00077	0.0283	CbGeAlD
Lovastatin—Simvastatin—UGT1A1—hematologic cancer	0.000764	0.497	CrCbGaD
Lovastatin—ABCB1—Doxorubicin—hematologic cancer	0.00072	0.00189	CbGbCtD
Lovastatin—CYP3A4—Vinblastine—hematologic cancer	0.000702	0.00185	CbGbCtD
Lovastatin—HMGCR—hematopoietic system—hematologic cancer	0.000699	0.0257	CbGeAlD
Lovastatin—ABCB1—Methotrexate—hematologic cancer	0.000697	0.00183	CbGbCtD
Lovastatin—CYP3A4—Vincristine—hematologic cancer	0.00069	0.00181	CbGbCtD
Lovastatin—CYP2D6—Doxorubicin—hematologic cancer	0.000678	0.00178	CbGbCtD
Lovastatin—SLCO1B1—hematopoietic system—hematologic cancer	0.00067	0.0246	CbGeAlD
Lovastatin—HDAC2—Topotecan—Irinotecan—hematologic cancer	0.000645	0.494	CbGdCrCtD
Lovastatin—CYP3A4—Etoposide—hematologic cancer	0.000632	0.00166	CbGbCtD
Lovastatin—HDAC2—gonad—hematologic cancer	0.000589	0.0216	CbGeAlD
Lovastatin—SLCO1A2—hematopoietic system—hematologic cancer	0.000545	0.02	CbGeAlD
Lovastatin—UGT1A1—blood—hematologic cancer	0.000533	0.0196	CbGeAlD
Lovastatin—HMGCR—gonad—hematologic cancer	0.000531	0.0195	CbGeAlD
Lovastatin—CYP3A4—Dexamethasone—hematologic cancer	0.00052	0.00137	CbGbCtD
Lovastatin—UGT2B7—testis—hematologic cancer	0.000519	0.0191	CbGeAlD
Lovastatin—HDAC2—blood—hematologic cancer	0.000513	0.0189	CbGeAlD
Lovastatin—HDAC2—bone marrow—hematologic cancer	0.000497	0.0182	CbGeAlD
Lovastatin—HMGCR—blood—hematologic cancer	0.000463	0.017	CbGeAlD
Lovastatin—HDAC2—lung—hematologic cancer	0.00045	0.0165	CbGeAlD
Lovastatin—HMGCR—bone marrow—hematologic cancer	0.000448	0.0165	CbGeAlD
Lovastatin—SLCO1B1—blood—hematologic cancer	0.000444	0.0163	CbGeAlD
Lovastatin—CYP2C19—hematopoietic system—hematologic cancer	0.000436	0.016	CbGeAlD
Lovastatin—CYP3A4—Doxorubicin—hematologic cancer	0.000431	0.00113	CbGbCtD
Lovastatin—HDAC2—testis—hematologic cancer	0.000424	0.0156	CbGeAlD
Lovastatin—Pravastatin—ABCG2—hematologic cancer	0.00042	0.273	CrCbGaD
Lovastatin—HMGCR—lung—hematologic cancer	0.000406	0.0149	CbGeAlD
Lovastatin—HMGCR—testis—hematologic cancer	0.000383	0.0141	CbGeAlD
Lovastatin—CYP2C8—hematopoietic system—hematologic cancer	0.000381	0.014	CbGeAlD
Lovastatin—HDAC2—Menadione—Thalidomide—hematologic cancer	0.00037	0.284	CbGdCrCtD
Lovastatin—CYP3A5—hematopoietic system—hematologic cancer	0.000344	0.0126	CbGeAlD
Lovastatin—CYP2C9—hematopoietic system—hematologic cancer	0.000338	0.0124	CbGeAlD
Lovastatin—ABCC2—blood—hematologic cancer	0.000336	0.0124	CbGeAlD
Lovastatin—SLCO1A2—lung—hematologic cancer	0.000316	0.0116	CbGeAlD
Lovastatin—HDAC2—lymph node—hematologic cancer	0.000308	0.0113	CbGeAlD
Lovastatin—SLCO1A2—testis—hematologic cancer	0.000299	0.011	CbGeAlD
Lovastatin—HDAC2—Teniposide—Etoposide—hematologic cancer	0.000291	0.223	CbGdCrCtD
Lovastatin—CYP2C19—blood—hematologic cancer	0.000289	0.0106	CbGeAlD
Lovastatin—ABCC2—testis—hematologic cancer	0.000278	0.0102	CbGeAlD
Lovastatin—HMGCR—lymph node—hematologic cancer	0.000278	0.0102	CbGeAlD
Lovastatin—CYP3A4—hematopoietic system—hematologic cancer	0.000258	0.00947	CbGeAlD
Lovastatin—CYP2D6—hematopoietic system—hematologic cancer	0.000254	0.00932	CbGeAlD
Lovastatin—CYP2C8—blood—hematologic cancer	0.000252	0.00927	CbGeAlD
Lovastatin—CYP3A5—blood—hematologic cancer	0.000228	0.00836	CbGeAlD
Lovastatin—CYP2C9—blood—hematologic cancer	0.000224	0.00823	CbGeAlD
Lovastatin—CYP2C8—testis—hematologic cancer	0.000209	0.00767	CbGeAlD
Lovastatin—ABCC2—lymph node—hematologic cancer	0.000202	0.00741	CbGeAlD
Lovastatin—CYP3A5—lung—hematologic cancer	0.0002	0.00733	CbGeAlD
Lovastatin—ABCB1—hematopoietic system—hematologic cancer	0.000183	0.00671	CbGeAlD
Lovastatin—Simvastatin—ABCB1—hematologic cancer	0.000179	0.116	CrCbGaD
Lovastatin—Pravastatin—ABCB1—hematologic cancer	0.000175	0.114	CrCbGaD
Lovastatin—CYP3A4—blood—hematologic cancer	0.000171	0.00628	CbGeAlD
Lovastatin—CYP2D6—blood—hematologic cancer	0.000168	0.00618	CbGeAlD
Lovastatin—CYP2D6—testis—hematologic cancer	0.000139	0.00511	CbGeAlD
Lovastatin—ABCB1—gonad—hematologic cancer	0.000139	0.0051	CbGeAlD
Lovastatin—ABCB1—blood—hematologic cancer	0.000121	0.00444	CbGeAlD
Lovastatin—ABCB1—bone marrow—hematologic cancer	0.000117	0.0043	CbGeAlD
Lovastatin—ABCB1—lung—hematologic cancer	0.000106	0.0039	CbGeAlD
Lovastatin—ABCB1—testis—hematologic cancer	0.0001	0.00368	CbGeAlD
Lovastatin—ABCB1—lymph node—hematologic cancer	7.25e-05	0.00266	CbGeAlD
Lovastatin—Nausea—Ifosfamide—hematologic cancer	1.97e-05	0.000176	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.97e-05	0.000175	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.97e-05	0.000175	CcSEcCtD
Lovastatin—Myalgia—Prednisone—hematologic cancer	1.96e-05	0.000175	CcSEcCtD
Lovastatin—Arthralgia—Prednisone—hematologic cancer	1.96e-05	0.000175	CcSEcCtD
Lovastatin—Feeling abnormal—Triamcinolone—hematologic cancer	1.96e-05	0.000175	CcSEcCtD
Lovastatin—Diarrhoea—Cisplatin—hematologic cancer	1.96e-05	0.000174	CcSEcCtD
Lovastatin—Erythema multiforme—Epirubicin—hematologic cancer	1.96e-05	0.000174	CcSEcCtD
Lovastatin—Anxiety—Prednisone—hematologic cancer	1.96e-05	0.000174	CcSEcCtD
Lovastatin—Alopecia—Methotrexate—hematologic cancer	1.96e-05	0.000174	CcSEcCtD
Lovastatin—Vomiting—Gemcitabine—hematologic cancer	1.95e-05	0.000174	CcSEcCtD
Lovastatin—Insomnia—Dexamethasone—hematologic cancer	1.95e-05	0.000174	CcSEcCtD
Lovastatin—Insomnia—Betamethasone—hematologic cancer	1.95e-05	0.000174	CcSEcCtD
Lovastatin—Paraesthesia—Dexamethasone—hematologic cancer	1.94e-05	0.000173	CcSEcCtD
Lovastatin—Paraesthesia—Betamethasone—hematologic cancer	1.94e-05	0.000173	CcSEcCtD
Lovastatin—Discomfort—Prednisone—hematologic cancer	1.94e-05	0.000173	CcSEcCtD
Lovastatin—Rash—Gemcitabine—hematologic cancer	1.94e-05	0.000172	CcSEcCtD
Lovastatin—Dermatitis—Gemcitabine—hematologic cancer	1.94e-05	0.000172	CcSEcCtD
Lovastatin—Hypersensitivity—Etoposide—hematologic cancer	1.93e-05	0.000172	CcSEcCtD
Lovastatin—Headache—Gemcitabine—hematologic cancer	1.93e-05	0.000171	CcSEcCtD
Lovastatin—Nausea—Vincristine—hematologic cancer	1.92e-05	0.000171	CcSEcCtD
Lovastatin—Flushing—Epirubicin—hematologic cancer	1.92e-05	0.000171	CcSEcCtD
Lovastatin—Hepatitis—Doxorubicin—hematologic cancer	1.92e-05	0.000171	CcSEcCtD
Lovastatin—Hypersensitivity—Prednisolone—hematologic cancer	1.91e-05	0.00017	CcSEcCtD
Lovastatin—Dyspepsia—Betamethasone—hematologic cancer	1.9e-05	0.000169	CcSEcCtD
Lovastatin—Dyspepsia—Dexamethasone—hematologic cancer	1.9e-05	0.000169	CcSEcCtD
Lovastatin—Urticaria—Triamcinolone—hematologic cancer	1.89e-05	0.000168	CcSEcCtD
Lovastatin—Dysgeusia—Methotrexate—hematologic cancer	1.89e-05	0.000168	CcSEcCtD
Lovastatin—Asthenia—Etoposide—hematologic cancer	1.88e-05	0.000168	CcSEcCtD
Lovastatin—Body temperature increased—Triamcinolone—hematologic cancer	1.88e-05	0.000167	CcSEcCtD
Lovastatin—Anaphylactic shock—Prednisone—hematologic cancer	1.88e-05	0.000167	CcSEcCtD
Lovastatin—Decreased appetite—Betamethasone—hematologic cancer	1.88e-05	0.000167	CcSEcCtD
Lovastatin—Decreased appetite—Dexamethasone—hematologic cancer	1.88e-05	0.000167	CcSEcCtD
Lovastatin—Nausea—Mitoxantrone—hematologic cancer	1.87e-05	0.000167	CcSEcCtD
Lovastatin—Nausea—Irinotecan—hematologic cancer	1.87e-05	0.000167	CcSEcCtD
Lovastatin—Infection—Prednisone—hematologic cancer	1.87e-05	0.000166	CcSEcCtD
Lovastatin—Back pain—Methotrexate—hematologic cancer	1.86e-05	0.000166	CcSEcCtD
Lovastatin—Fatigue—Betamethasone—hematologic cancer	1.86e-05	0.000166	CcSEcCtD
Lovastatin—Fatigue—Dexamethasone—hematologic cancer	1.86e-05	0.000166	CcSEcCtD
Lovastatin—Chills—Epirubicin—hematologic cancer	1.86e-05	0.000165	CcSEcCtD
Lovastatin—Pruritus—Etoposide—hematologic cancer	1.86e-05	0.000165	CcSEcCtD
Lovastatin—Pain—Betamethasone—hematologic cancer	1.85e-05	0.000164	CcSEcCtD
Lovastatin—Pain—Dexamethasone—hematologic cancer	1.85e-05	0.000164	CcSEcCtD
Lovastatin—Alopecia—Epirubicin—hematologic cancer	1.83e-05	0.000163	CcSEcCtD
Lovastatin—Nausea—Gemcitabine—hematologic cancer	1.83e-05	0.000162	CcSEcCtD
Lovastatin—Vomiting—Cisplatin—hematologic cancer	1.82e-05	0.000162	CcSEcCtD
Lovastatin—Vision blurred—Methotrexate—hematologic cancer	1.82e-05	0.000162	CcSEcCtD
Lovastatin—Erythema multiforme—Doxorubicin—hematologic cancer	1.81e-05	0.000161	CcSEcCtD
Lovastatin—Rash—Cisplatin—hematologic cancer	1.81e-05	0.000161	CcSEcCtD
Lovastatin—Dermatitis—Cisplatin—hematologic cancer	1.81e-05	0.000161	CcSEcCtD
Lovastatin—Diarrhoea—Etoposide—hematologic cancer	1.8e-05	0.00016	CcSEcCtD
Lovastatin—Anorexia—Prednisone—hematologic cancer	1.79e-05	0.00016	CcSEcCtD
Lovastatin—Ill-defined disorder—Methotrexate—hematologic cancer	1.79e-05	0.000159	CcSEcCtD
Lovastatin—Feeling abnormal—Betamethasone—hematologic cancer	1.78e-05	0.000158	CcSEcCtD
Lovastatin—Feeling abnormal—Dexamethasone—hematologic cancer	1.78e-05	0.000158	CcSEcCtD
Lovastatin—Flushing—Doxorubicin—hematologic cancer	1.78e-05	0.000158	CcSEcCtD
Lovastatin—Flatulence—Epirubicin—hematologic cancer	1.78e-05	0.000158	CcSEcCtD
Lovastatin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.77e-05	0.000157	CcSEcCtD
Lovastatin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.77e-05	0.000157	CcSEcCtD
Lovastatin—Dysgeusia—Epirubicin—hematologic cancer	1.77e-05	0.000157	CcSEcCtD
Lovastatin—Hypersensitivity—Triamcinolone—hematologic cancer	1.75e-05	0.000156	CcSEcCtD
Lovastatin—Back pain—Epirubicin—hematologic cancer	1.74e-05	0.000155	CcSEcCtD
Lovastatin—Malaise—Methotrexate—hematologic cancer	1.74e-05	0.000155	CcSEcCtD
Lovastatin—Dizziness—Etoposide—hematologic cancer	1.74e-05	0.000154	CcSEcCtD
Lovastatin—Muscle spasms—Epirubicin—hematologic cancer	1.73e-05	0.000154	CcSEcCtD
Lovastatin—Vertigo—Methotrexate—hematologic cancer	1.73e-05	0.000154	CcSEcCtD
Lovastatin—Leukopenia—Methotrexate—hematologic cancer	1.72e-05	0.000153	CcSEcCtD
Lovastatin—Chills—Doxorubicin—hematologic cancer	1.72e-05	0.000153	CcSEcCtD
Lovastatin—Urticaria—Betamethasone—hematologic cancer	1.72e-05	0.000153	CcSEcCtD
Lovastatin—Urticaria—Dexamethasone—hematologic cancer	1.72e-05	0.000153	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.71e-05	0.000153	CcSEcCtD
Lovastatin—Dizziness—Prednisolone—hematologic cancer	1.71e-05	0.000152	CcSEcCtD
Lovastatin—Asthenia—Triamcinolone—hematologic cancer	1.71e-05	0.000152	CcSEcCtD
Lovastatin—Abdominal pain—Dexamethasone—hematologic cancer	1.71e-05	0.000152	CcSEcCtD
Lovastatin—Body temperature increased—Betamethasone—hematologic cancer	1.71e-05	0.000152	CcSEcCtD
Lovastatin—Abdominal pain—Betamethasone—hematologic cancer	1.71e-05	0.000152	CcSEcCtD
Lovastatin—Body temperature increased—Dexamethasone—hematologic cancer	1.71e-05	0.000152	CcSEcCtD
Lovastatin—Nausea—Cisplatin—hematologic cancer	1.7e-05	0.000151	CcSEcCtD
Lovastatin—Insomnia—Prednisone—hematologic cancer	1.7e-05	0.000151	CcSEcCtD
Lovastatin—Vision blurred—Epirubicin—hematologic cancer	1.7e-05	0.000151	CcSEcCtD
Lovastatin—Alopecia—Doxorubicin—hematologic cancer	1.69e-05	0.000151	CcSEcCtD
Lovastatin—Paraesthesia—Prednisone—hematologic cancer	1.69e-05	0.00015	CcSEcCtD
Lovastatin—Pruritus—Triamcinolone—hematologic cancer	1.68e-05	0.00015	CcSEcCtD
Lovastatin—Ill-defined disorder—Epirubicin—hematologic cancer	1.67e-05	0.000149	CcSEcCtD
Lovastatin—Vomiting—Etoposide—hematologic cancer	1.67e-05	0.000149	CcSEcCtD
Lovastatin—Dyspepsia—Prednisone—hematologic cancer	1.66e-05	0.000147	CcSEcCtD
Lovastatin—Rash—Etoposide—hematologic cancer	1.66e-05	0.000147	CcSEcCtD
Lovastatin—Dermatitis—Etoposide—hematologic cancer	1.65e-05	0.000147	CcSEcCtD
Lovastatin—Headache—Etoposide—hematologic cancer	1.64e-05	0.000146	CcSEcCtD
Lovastatin—Flatulence—Doxorubicin—hematologic cancer	1.64e-05	0.000146	CcSEcCtD
Lovastatin—Myalgia—Methotrexate—hematologic cancer	1.64e-05	0.000146	CcSEcCtD
Lovastatin—Chest pain—Methotrexate—hematologic cancer	1.64e-05	0.000146	CcSEcCtD
Lovastatin—Arthralgia—Methotrexate—hematologic cancer	1.64e-05	0.000146	CcSEcCtD
Lovastatin—Decreased appetite—Prednisone—hematologic cancer	1.64e-05	0.000146	CcSEcCtD
Lovastatin—Dysgeusia—Doxorubicin—hematologic cancer	1.63e-05	0.000145	CcSEcCtD
Lovastatin—Rash—Prednisolone—hematologic cancer	1.63e-05	0.000145	CcSEcCtD
Lovastatin—Dermatitis—Prednisolone—hematologic cancer	1.63e-05	0.000145	CcSEcCtD
Lovastatin—Malaise—Epirubicin—hematologic cancer	1.63e-05	0.000145	CcSEcCtD
Lovastatin—Fatigue—Prednisone—hematologic cancer	1.62e-05	0.000144	CcSEcCtD
Lovastatin—Headache—Prednisolone—hematologic cancer	1.62e-05	0.000144	CcSEcCtD
Lovastatin—Discomfort—Methotrexate—hematologic cancer	1.62e-05	0.000144	CcSEcCtD
Lovastatin—Vertigo—Epirubicin—hematologic cancer	1.62e-05	0.000144	CcSEcCtD
Lovastatin—Leukopenia—Epirubicin—hematologic cancer	1.61e-05	0.000144	CcSEcCtD
Lovastatin—Back pain—Doxorubicin—hematologic cancer	1.61e-05	0.000144	CcSEcCtD
Lovastatin—Constipation—Prednisone—hematologic cancer	1.61e-05	0.000143	CcSEcCtD
Lovastatin—Muscle spasms—Doxorubicin—hematologic cancer	1.6e-05	0.000143	CcSEcCtD
Lovastatin—Confusional state—Methotrexate—hematologic cancer	1.59e-05	0.000141	CcSEcCtD
Lovastatin—Dizziness—Triamcinolone—hematologic cancer	1.57e-05	0.00014	CcSEcCtD
Lovastatin—Anaphylactic shock—Methotrexate—hematologic cancer	1.57e-05	0.00014	CcSEcCtD
Lovastatin—Vision blurred—Doxorubicin—hematologic cancer	1.57e-05	0.00014	CcSEcCtD
Lovastatin—Infection—Methotrexate—hematologic cancer	1.56e-05	0.000139	CcSEcCtD
Lovastatin—Nausea—Etoposide—hematologic cancer	1.56e-05	0.000139	CcSEcCtD
Lovastatin—Feeling abnormal—Prednisone—hematologic cancer	1.55e-05	0.000138	CcSEcCtD
Lovastatin—Asthenia—Dexamethasone—hematologic cancer	1.55e-05	0.000138	CcSEcCtD
Lovastatin—Asthenia—Betamethasone—hematologic cancer	1.55e-05	0.000138	CcSEcCtD
Lovastatin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.55e-05	0.000138	CcSEcCtD
Lovastatin—Thrombocytopenia—Methotrexate—hematologic cancer	1.54e-05	0.000137	CcSEcCtD
Lovastatin—Gastrointestinal pain—Prednisone—hematologic cancer	1.54e-05	0.000137	CcSEcCtD
Lovastatin—Nausea—Prednisolone—hematologic cancer	1.54e-05	0.000137	CcSEcCtD
Lovastatin—Chest pain—Epirubicin—hematologic cancer	1.54e-05	0.000137	CcSEcCtD
Lovastatin—Arthralgia—Epirubicin—hematologic cancer	1.54e-05	0.000137	CcSEcCtD
Lovastatin—Myalgia—Epirubicin—hematologic cancer	1.54e-05	0.000137	CcSEcCtD
Lovastatin—Anxiety—Epirubicin—hematologic cancer	1.53e-05	0.000136	CcSEcCtD
Lovastatin—Pruritus—Betamethasone—hematologic cancer	1.53e-05	0.000136	CcSEcCtD
Lovastatin—Pruritus—Dexamethasone—hematologic cancer	1.53e-05	0.000136	CcSEcCtD
Lovastatin—Discomfort—Epirubicin—hematologic cancer	1.52e-05	0.000135	CcSEcCtD
Lovastatin—Vomiting—Triamcinolone—hematologic cancer	1.51e-05	0.000135	CcSEcCtD
Lovastatin—Malaise—Doxorubicin—hematologic cancer	1.5e-05	0.000134	CcSEcCtD
Lovastatin—Rash—Triamcinolone—hematologic cancer	1.5e-05	0.000134	CcSEcCtD
Lovastatin—Dry mouth—Epirubicin—hematologic cancer	1.5e-05	0.000134	CcSEcCtD
Lovastatin—Dermatitis—Triamcinolone—hematologic cancer	1.5e-05	0.000133	CcSEcCtD
Lovastatin—Vertigo—Doxorubicin—hematologic cancer	1.5e-05	0.000133	CcSEcCtD
Lovastatin—Anorexia—Methotrexate—hematologic cancer	1.5e-05	0.000133	CcSEcCtD
Lovastatin—Urticaria—Prednisone—hematologic cancer	1.49e-05	0.000133	CcSEcCtD
Lovastatin—Leukopenia—Doxorubicin—hematologic cancer	1.49e-05	0.000133	CcSEcCtD
Lovastatin—Headache—Triamcinolone—hematologic cancer	1.49e-05	0.000133	CcSEcCtD
Lovastatin—Body temperature increased—Prednisone—hematologic cancer	1.49e-05	0.000132	CcSEcCtD
Lovastatin—Abdominal pain—Prednisone—hematologic cancer	1.49e-05	0.000132	CcSEcCtD
Lovastatin—Confusional state—Epirubicin—hematologic cancer	1.48e-05	0.000132	CcSEcCtD
Lovastatin—Diarrhoea—Betamethasone—hematologic cancer	1.48e-05	0.000132	CcSEcCtD
Lovastatin—Diarrhoea—Dexamethasone—hematologic cancer	1.48e-05	0.000132	CcSEcCtD
Lovastatin—Anaphylactic shock—Epirubicin—hematologic cancer	1.47e-05	0.000131	CcSEcCtD
Lovastatin—Infection—Epirubicin—hematologic cancer	1.46e-05	0.00013	CcSEcCtD
Lovastatin—Thrombocytopenia—Epirubicin—hematologic cancer	1.44e-05	0.000128	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.43e-05	0.000127	CcSEcCtD
Lovastatin—Dizziness—Dexamethasone—hematologic cancer	1.43e-05	0.000127	CcSEcCtD
Lovastatin—Dizziness—Betamethasone—hematologic cancer	1.43e-05	0.000127	CcSEcCtD
Lovastatin—Insomnia—Methotrexate—hematologic cancer	1.42e-05	0.000127	CcSEcCtD
Lovastatin—Chest pain—Doxorubicin—hematologic cancer	1.42e-05	0.000126	CcSEcCtD
Lovastatin—Arthralgia—Doxorubicin—hematologic cancer	1.42e-05	0.000126	CcSEcCtD
Lovastatin—Myalgia—Doxorubicin—hematologic cancer	1.42e-05	0.000126	CcSEcCtD
Lovastatin—Anxiety—Doxorubicin—hematologic cancer	1.42e-05	0.000126	CcSEcCtD
Lovastatin—Nausea—Triamcinolone—hematologic cancer	1.41e-05	0.000126	CcSEcCtD
Lovastatin—Paraesthesia—Methotrexate—hematologic cancer	1.41e-05	0.000126	CcSEcCtD
Lovastatin—Discomfort—Doxorubicin—hematologic cancer	1.4e-05	0.000125	CcSEcCtD
Lovastatin—Anorexia—Epirubicin—hematologic cancer	1.4e-05	0.000125	CcSEcCtD
Lovastatin—Dyspnoea—Methotrexate—hematologic cancer	1.4e-05	0.000125	CcSEcCtD
Lovastatin—Dry mouth—Doxorubicin—hematologic cancer	1.39e-05	0.000124	CcSEcCtD
Lovastatin—Hypersensitivity—Prednisone—hematologic cancer	1.39e-05	0.000123	CcSEcCtD
Lovastatin—Dyspepsia—Methotrexate—hematologic cancer	1.38e-05	0.000123	CcSEcCtD
Lovastatin—Vomiting—Betamethasone—hematologic cancer	1.37e-05	0.000122	CcSEcCtD
Lovastatin—Vomiting—Dexamethasone—hematologic cancer	1.37e-05	0.000122	CcSEcCtD
Lovastatin—Confusional state—Doxorubicin—hematologic cancer	1.37e-05	0.000122	CcSEcCtD
Lovastatin—Decreased appetite—Methotrexate—hematologic cancer	1.37e-05	0.000122	CcSEcCtD
Lovastatin—Rash—Dexamethasone—hematologic cancer	1.36e-05	0.000121	CcSEcCtD
Lovastatin—Rash—Betamethasone—hematologic cancer	1.36e-05	0.000121	CcSEcCtD
Lovastatin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.36e-05	0.000121	CcSEcCtD
Lovastatin—Dermatitis—Dexamethasone—hematologic cancer	1.36e-05	0.000121	CcSEcCtD
Lovastatin—Dermatitis—Betamethasone—hematologic cancer	1.36e-05	0.000121	CcSEcCtD
Lovastatin—Fatigue—Methotrexate—hematologic cancer	1.36e-05	0.000121	CcSEcCtD
Lovastatin—Headache—Dexamethasone—hematologic cancer	1.35e-05	0.00012	CcSEcCtD
Lovastatin—Headache—Betamethasone—hematologic cancer	1.35e-05	0.00012	CcSEcCtD
Lovastatin—Infection—Doxorubicin—hematologic cancer	1.35e-05	0.00012	CcSEcCtD
Lovastatin—Asthenia—Prednisone—hematologic cancer	1.35e-05	0.00012	CcSEcCtD
Lovastatin—Pain—Methotrexate—hematologic cancer	1.34e-05	0.00012	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.34e-05	0.000119	CcSEcCtD
Lovastatin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.33e-05	0.000119	CcSEcCtD
Lovastatin—Pruritus—Prednisone—hematologic cancer	1.33e-05	0.000118	CcSEcCtD
Lovastatin—Insomnia—Epirubicin—hematologic cancer	1.33e-05	0.000118	CcSEcCtD
Lovastatin—Paraesthesia—Epirubicin—hematologic cancer	1.32e-05	0.000118	CcSEcCtD
Lovastatin—Dyspnoea—Epirubicin—hematologic cancer	1.31e-05	0.000117	CcSEcCtD
Lovastatin—Anorexia—Doxorubicin—hematologic cancer	1.3e-05	0.000115	CcSEcCtD
Lovastatin—Feeling abnormal—Methotrexate—hematologic cancer	1.3e-05	0.000115	CcSEcCtD
Lovastatin—Dyspepsia—Epirubicin—hematologic cancer	1.3e-05	0.000115	CcSEcCtD
Lovastatin—Diarrhoea—Prednisone—hematologic cancer	1.29e-05	0.000115	CcSEcCtD
Lovastatin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.29e-05	0.000114	CcSEcCtD
Lovastatin—Nausea—Betamethasone—hematologic cancer	1.28e-05	0.000114	CcSEcCtD
Lovastatin—Nausea—Dexamethasone—hematologic cancer	1.28e-05	0.000114	CcSEcCtD
Lovastatin—Decreased appetite—Epirubicin—hematologic cancer	1.28e-05	0.000114	CcSEcCtD
Lovastatin—Fatigue—Epirubicin—hematologic cancer	1.27e-05	0.000113	CcSEcCtD
Lovastatin—Constipation—Epirubicin—hematologic cancer	1.26e-05	0.000112	CcSEcCtD
Lovastatin—Pain—Epirubicin—hematologic cancer	1.26e-05	0.000112	CcSEcCtD
Lovastatin—Urticaria—Methotrexate—hematologic cancer	1.25e-05	0.000111	CcSEcCtD
Lovastatin—Dizziness—Prednisone—hematologic cancer	1.24e-05	0.000111	CcSEcCtD
Lovastatin—Body temperature increased—Methotrexate—hematologic cancer	1.24e-05	0.000111	CcSEcCtD
Lovastatin—Abdominal pain—Methotrexate—hematologic cancer	1.24e-05	0.000111	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.24e-05	0.00011	CcSEcCtD
Lovastatin—Insomnia—Doxorubicin—hematologic cancer	1.23e-05	0.00011	CcSEcCtD
Lovastatin—Paraesthesia—Doxorubicin—hematologic cancer	1.22e-05	0.000109	CcSEcCtD
Lovastatin—Dyspnoea—Doxorubicin—hematologic cancer	1.21e-05	0.000108	CcSEcCtD
Lovastatin—Feeling abnormal—Epirubicin—hematologic cancer	1.21e-05	0.000108	CcSEcCtD
Lovastatin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.2e-05	0.000107	CcSEcCtD
Lovastatin—Dyspepsia—Doxorubicin—hematologic cancer	1.2e-05	0.000107	CcSEcCtD
Lovastatin—Vomiting—Prednisone—hematologic cancer	1.2e-05	0.000106	CcSEcCtD
Lovastatin—Rash—Prednisone—hematologic cancer	1.19e-05	0.000106	CcSEcCtD
Lovastatin—Dermatitis—Prednisone—hematologic cancer	1.19e-05	0.000105	CcSEcCtD
Lovastatin—Decreased appetite—Doxorubicin—hematologic cancer	1.18e-05	0.000105	CcSEcCtD
Lovastatin—Headache—Prednisone—hematologic cancer	1.18e-05	0.000105	CcSEcCtD
Lovastatin—Fatigue—Doxorubicin—hematologic cancer	1.17e-05	0.000104	CcSEcCtD
Lovastatin—Urticaria—Epirubicin—hematologic cancer	1.17e-05	0.000104	CcSEcCtD
Lovastatin—Pain—Doxorubicin—hematologic cancer	1.16e-05	0.000104	CcSEcCtD
Lovastatin—Constipation—Doxorubicin—hematologic cancer	1.16e-05	0.000104	CcSEcCtD
Lovastatin—Body temperature increased—Epirubicin—hematologic cancer	1.16e-05	0.000104	CcSEcCtD
Lovastatin—Abdominal pain—Epirubicin—hematologic cancer	1.16e-05	0.000104	CcSEcCtD
Lovastatin—Hypersensitivity—Methotrexate—hematologic cancer	1.16e-05	0.000103	CcSEcCtD
Lovastatin—Asthenia—Methotrexate—hematologic cancer	1.13e-05	0.0001	CcSEcCtD
Lovastatin—Feeling abnormal—Doxorubicin—hematologic cancer	1.12e-05	9.98e-05	CcSEcCtD
Lovastatin—Nausea—Prednisone—hematologic cancer	1.12e-05	9.94e-05	CcSEcCtD
Lovastatin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.11e-05	9.91e-05	CcSEcCtD
Lovastatin—Pruritus—Methotrexate—hematologic cancer	1.11e-05	9.9e-05	CcSEcCtD
Lovastatin—Hypersensitivity—Epirubicin—hematologic cancer	1.08e-05	9.65e-05	CcSEcCtD
Lovastatin—Urticaria—Doxorubicin—hematologic cancer	1.08e-05	9.62e-05	CcSEcCtD
Lovastatin—Abdominal pain—Doxorubicin—hematologic cancer	1.08e-05	9.58e-05	CcSEcCtD
Lovastatin—Body temperature increased—Doxorubicin—hematologic cancer	1.08e-05	9.58e-05	CcSEcCtD
Lovastatin—Diarrhoea—Methotrexate—hematologic cancer	1.08e-05	9.57e-05	CcSEcCtD
Lovastatin—Asthenia—Epirubicin—hematologic cancer	1.06e-05	9.39e-05	CcSEcCtD
Lovastatin—Pruritus—Epirubicin—hematologic cancer	1.04e-05	9.26e-05	CcSEcCtD
Lovastatin—Dizziness—Methotrexate—hematologic cancer	1.04e-05	9.25e-05	CcSEcCtD
Lovastatin—Diarrhoea—Epirubicin—hematologic cancer	1.01e-05	8.96e-05	CcSEcCtD
Lovastatin—Hypersensitivity—Doxorubicin—hematologic cancer	1e-05	8.93e-05	CcSEcCtD
Lovastatin—Vomiting—Methotrexate—hematologic cancer	1e-05	8.9e-05	CcSEcCtD
Lovastatin—Rash—Methotrexate—hematologic cancer	9.91e-06	8.82e-05	CcSEcCtD
Lovastatin—Dermatitis—Methotrexate—hematologic cancer	9.91e-06	8.81e-05	CcSEcCtD
Lovastatin—Headache—Methotrexate—hematologic cancer	9.85e-06	8.76e-05	CcSEcCtD
Lovastatin—Asthenia—Doxorubicin—hematologic cancer	9.77e-06	8.69e-05	CcSEcCtD
Lovastatin—Dizziness—Epirubicin—hematologic cancer	9.73e-06	8.66e-05	CcSEcCtD
Lovastatin—Pruritus—Doxorubicin—hematologic cancer	9.63e-06	8.57e-05	CcSEcCtD
Lovastatin—Vomiting—Epirubicin—hematologic cancer	9.36e-06	8.32e-05	CcSEcCtD
Lovastatin—Nausea—Methotrexate—hematologic cancer	9.34e-06	8.31e-05	CcSEcCtD
Lovastatin—Diarrhoea—Doxorubicin—hematologic cancer	9.32e-06	8.29e-05	CcSEcCtD
Lovastatin—Rash—Epirubicin—hematologic cancer	9.28e-06	8.26e-05	CcSEcCtD
Lovastatin—Dermatitis—Epirubicin—hematologic cancer	9.27e-06	8.25e-05	CcSEcCtD
Lovastatin—Headache—Epirubicin—hematologic cancer	9.22e-06	8.2e-05	CcSEcCtD
Lovastatin—Dizziness—Doxorubicin—hematologic cancer	9e-06	8.01e-05	CcSEcCtD
Lovastatin—Nausea—Epirubicin—hematologic cancer	8.74e-06	7.78e-05	CcSEcCtD
Lovastatin—Vomiting—Doxorubicin—hematologic cancer	8.66e-06	7.7e-05	CcSEcCtD
Lovastatin—Rash—Doxorubicin—hematologic cancer	8.59e-06	7.64e-05	CcSEcCtD
Lovastatin—Dermatitis—Doxorubicin—hematologic cancer	8.58e-06	7.63e-05	CcSEcCtD
Lovastatin—Headache—Doxorubicin—hematologic cancer	8.53e-06	7.59e-05	CcSEcCtD
Lovastatin—Nausea—Doxorubicin—hematologic cancer	8.09e-06	7.2e-05	CcSEcCtD
Lovastatin—UGT1A1—Metabolism—CREBBP—hematologic cancer	1.56e-06	2.03e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CD44—hematologic cancer	1.56e-06	2.02e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NQO1—hematologic cancer	1.56e-06	2.02e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	1.54e-06	2e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.54e-06	2e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.54e-06	2e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—EP300—hematologic cancer	1.54e-06	2e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CB—hematologic cancer	1.53e-06	1.99e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MTOR—hematologic cancer	1.53e-06	1.99e-05	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.53e-06	1.99e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HMMR—hematologic cancer	1.52e-06	1.98e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—IDH2—hematologic cancer	1.52e-06	1.98e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.52e-06	1.98e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.52e-06	1.98e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SDC1—hematologic cancer	1.5e-06	1.95e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.5e-06	1.95e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTP1—hematologic cancer	1.5e-06	1.95e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	1.5e-06	1.94e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SDC1—hematologic cancer	1.49e-06	1.94e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CD—hematologic cancer	1.48e-06	1.92e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.47e-06	1.92e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYCS—hematologic cancer	1.47e-06	1.91e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	1.46e-06	1.9e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ALB—hematologic cancer	1.46e-06	1.9e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—KRAS—hematologic cancer	1.45e-06	1.88e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN1B—hematologic cancer	1.44e-06	1.87e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.43e-06	1.86e-05	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.43e-06	1.86e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CREBBP—hematologic cancer	1.43e-06	1.86e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.42e-06	1.85e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ABCB1—hematologic cancer	1.42e-06	1.84e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CG—hematologic cancer	1.41e-06	1.84e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CASP3—hematologic cancer	1.41e-06	1.83e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2—hematologic cancer	1.4e-06	1.83e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.4e-06	1.83e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3R1—hematologic cancer	1.4e-06	1.81e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PIK3CA—hematologic cancer	1.4e-06	1.81e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ACP5—hematologic cancer	1.39e-06	1.81e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CA9—hematologic cancer	1.39e-06	1.81e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NQO1—hematologic cancer	1.39e-06	1.81e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CD44—hematologic cancer	1.39e-06	1.81e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	1.38e-06	1.8e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTM1—hematologic cancer	1.38e-06	1.79e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NCOR1—hematologic cancer	1.38e-06	1.79e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.38e-06	1.79e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTEN—hematologic cancer	1.37e-06	1.78e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCND1—hematologic cancer	1.37e-06	1.78e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—JUN—hematologic cancer	1.37e-06	1.78e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.36e-06	1.77e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CD44—hematologic cancer	1.36e-06	1.76e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NQO1—hematologic cancer	1.36e-06	1.76e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	1.36e-06	1.76e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.34e-06	1.75e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALB—hematologic cancer	1.34e-06	1.74e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PIK3CA—hematologic cancer	1.33e-06	1.73e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN1A—hematologic cancer	1.32e-06	1.72e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTEN—hematologic cancer	1.32e-06	1.72e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.32e-06	1.71e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYCS—hematologic cancer	1.31e-06	1.71e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CREBBP—hematologic cancer	1.31e-06	1.7e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—IDH1—hematologic cancer	1.31e-06	1.7e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—EP300—hematologic cancer	1.31e-06	1.7e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	1.31e-06	1.7e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTP1—hematologic cancer	1.3e-06	1.69e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TXN—hematologic cancer	1.3e-06	1.68e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.3e-06	1.68e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.3e-06	1.68e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK8—hematologic cancer	1.29e-06	1.68e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CB—hematologic cancer	1.29e-06	1.68e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYCS—hematologic cancer	1.28e-06	1.67e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	1.28e-06	1.66e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CD44—hematologic cancer	1.28e-06	1.66e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NQO1—hematologic cancer	1.28e-06	1.66e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—HSP90AA1—hematologic cancer	1.27e-06	1.66e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.27e-06	1.65e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NQO1—hematologic cancer	1.27e-06	1.65e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CD44—hematologic cancer	1.27e-06	1.65e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EP300—hematologic cancer	1.26e-06	1.64e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.26e-06	1.63e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CD—hematologic cancer	1.24e-06	1.62e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.24e-06	1.61e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HRAS—hematologic cancer	1.23e-06	1.6e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ABCB1—hematologic cancer	1.23e-06	1.6e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—hematologic cancer	1.23e-06	1.6e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SRC—hematologic cancer	1.23e-06	1.59e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.22e-06	1.58e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MTHFR—hematologic cancer	1.22e-06	1.58e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYCS—hematologic cancer	1.21e-06	1.57e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.2e-06	1.56e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYCS—hematologic cancer	1.2e-06	1.56e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—hematologic cancer	1.19e-06	1.55e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTEN—hematologic cancer	1.19e-06	1.55e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.19e-06	1.55e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.19e-06	1.55e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.19e-06	1.55e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.19e-06	1.54e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.19e-06	1.54e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT3—hematologic cancer	1.18e-06	1.54e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	1.18e-06	1.54e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NRAS—hematologic cancer	1.18e-06	1.53e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—hematologic cancer	1.18e-06	1.53e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.18e-06	1.53e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3R1—hematologic cancer	1.17e-06	1.53e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—hematologic cancer	1.17e-06	1.52e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTP1—hematologic cancer	1.16e-06	1.51e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.16e-06	1.5e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—hematologic cancer	1.14e-06	1.48e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—EP300—hematologic cancer	1.14e-06	1.48e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CA—hematologic cancer	1.14e-06	1.48e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTP1—hematologic cancer	1.13e-06	1.47e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK3—hematologic cancer	1.13e-06	1.47e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.12e-06	1.46e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NUP98—hematologic cancer	1.12e-06	1.45e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTEN—hematologic cancer	1.11e-06	1.45e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—hematologic cancer	1.1e-06	1.43e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ABCB1—hematologic cancer	1.1e-06	1.43e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TGFB1—hematologic cancer	1.1e-06	1.42e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—hematologic cancer	1.09e-06	1.41e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.09e-06	1.41e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.09e-06	1.41e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CB—hematologic cancer	1.08e-06	1.41e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NUP214—hematologic cancer	1.08e-06	1.4e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.07e-06	1.39e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTP1—hematologic cancer	1.07e-06	1.39e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NCOR1—hematologic cancer	1.06e-06	1.38e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTM1—hematologic cancer	1.06e-06	1.38e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—EP300—hematologic cancer	1.06e-06	1.38e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTR—hematologic cancer	1.06e-06	1.37e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.06e-06	1.37e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTP1—hematologic cancer	1.06e-06	1.37e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.05e-06	1.37e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NCOR1—hematologic cancer	1.04e-06	1.35e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTM1—hematologic cancer	1.04e-06	1.35e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ENO2—hematologic cancer	1.04e-06	1.35e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CG—hematologic cancer	1.02e-06	1.33e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.02e-06	1.33e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTEN—hematologic cancer	1.02e-06	1.33e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KRAS—hematologic cancer	1.02e-06	1.32e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ABCB1—hematologic cancer	1.01e-06	1.31e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.01e-06	1.31e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ABCB1—hematologic cancer	1e-06	1.3e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SDC1—hematologic cancer	9.82e-07	1.28e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTM1—hematologic cancer	9.79e-07	1.27e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NCOR1—hematologic cancer	9.79e-07	1.27e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—EP300—hematologic cancer	9.73e-07	1.27e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTM1—hematologic cancer	9.71e-07	1.26e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NCOR1—hematologic cancer	9.71e-07	1.26e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CA—hematologic cancer	9.67e-07	1.26e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CREBBP—hematologic cancer	9.48e-07	1.23e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MTHFR—hematologic cancer	9.41e-07	1.22e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTEN—hematologic cancer	9.37e-07	1.22e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CA—hematologic cancer	9.33e-07	1.21e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.29e-07	1.21e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—hematologic cancer	9.29e-07	1.21e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MTHFR—hematologic cancer	9.18e-07	1.19e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—hematologic cancer	9.02e-07	1.17e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CD—hematologic cancer	8.99e-07	1.17e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—EP300—hematologic cancer	8.93e-07	1.16e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—hematologic cancer	8.87e-07	1.15e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CG—hematologic cancer	8.86e-07	1.15e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MTHFR—hematologic cancer	8.66e-07	1.12e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRAS—hematologic cancer	8.63e-07	1.12e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MTHFR—hematologic cancer	8.58e-07	1.12e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3R1—hematologic cancer	8.49e-07	1.1e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	8.42e-07	1.09e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CD44—hematologic cancer	8.35e-07	1.09e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NQO1—hematologic cancer	8.35e-07	1.09e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.29e-07	1.08e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—hematologic cancer	8.26e-07	1.07e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CREBBP—hematologic cancer	8.21e-07	1.07e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CG—hematologic cancer	7.91e-07	1.03e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYCS—hematologic cancer	7.9e-07	1.03e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—hematologic cancer	7.9e-07	1.03e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CA—hematologic cancer	7.86e-07	1.02e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	7.85e-07	1.02e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CB—hematologic cancer	7.84e-07	1.02e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CD—hematologic cancer	7.79e-07	1.01e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CG—hematologic cancer	7.72e-07	1e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—hematologic cancer	7.69e-07	9.99e-06	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—hematologic cancer	7.62e-07	9.9e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.56e-07	9.83e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3R1—hematologic cancer	7.35e-07	9.56e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CREBBP—hematologic cancer	7.33e-07	9.53e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CG—hematologic cancer	7.27e-07	9.45e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	7.21e-07	9.37e-06	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	7.2e-07	9.36e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CREBBP—hematologic cancer	7.15e-07	9.3e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTP1—hematologic cancer	6.97e-07	9.06e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CD—hematologic cancer	6.95e-07	9.03e-06	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—hematologic cancer	6.88e-07	8.94e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—hematologic cancer	6.86e-07	8.92e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CB—hematologic cancer	6.79e-07	8.82e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CD—hematologic cancer	6.78e-07	8.82e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTEN—hematologic cancer	6.77e-07	8.8e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CREBBP—hematologic cancer	6.74e-07	8.76e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—hematologic cancer	6.7e-07	8.7e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CREBBP—hematologic cancer	6.68e-07	8.69e-06	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CA—hematologic cancer	6.61e-07	8.59e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCB1—hematologic cancer	6.6e-07	8.57e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3R1—hematologic cancer	6.56e-07	8.53e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—EP300—hematologic cancer	6.46e-07	8.39e-06	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—hematologic cancer	6.42e-07	8.34e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3R1—hematologic cancer	6.41e-07	8.33e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTM1—hematologic cancer	6.4e-07	8.32e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NCOR1—hematologic cancer	6.4e-07	8.32e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CD—hematologic cancer	6.39e-07	8.31e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	6.34e-07	8.24e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—hematologic cancer	6.31e-07	8.2e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—hematologic cancer	6.26e-07	8.13e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CB—hematologic cancer	6.06e-07	7.87e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3R1—hematologic cancer	6.04e-07	7.85e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	5.98e-07	7.78e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CB—hematologic cancer	5.91e-07	7.68e-06	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—hematologic cancer	5.88e-07	7.64e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTEN—hematologic cancer	5.86e-07	7.62e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTHFR—hematologic cancer	5.66e-07	7.35e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—EP300—hematologic cancer	5.59e-07	7.27e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CB—hematologic cancer	5.57e-07	7.24e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	5.52e-07	7.18e-06	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—hematologic cancer	5.4e-07	7.02e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTEN—hematologic cancer	5.23e-07	6.8e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTEN—hematologic cancer	5.11e-07	6.64e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—EP300—hematologic cancer	4.99e-07	6.49e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—EP300—hematologic cancer	4.87e-07	6.33e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTEN—hematologic cancer	4.81e-07	6.26e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CA—hematologic cancer	4.78e-07	6.21e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTEN—hematologic cancer	4.77e-07	6.2e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.75e-07	6.18e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—EP300—hematologic cancer	4.59e-07	5.97e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—EP300—hematologic cancer	4.55e-07	5.92e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.41e-07	5.73e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.18e-07	5.43e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CA—hematologic cancer	4.14e-07	5.38e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—hematologic cancer	4.13e-07	5.36e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.95e-07	5.13e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—hematologic cancer	3.9e-07	5.07e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CA—hematologic cancer	3.69e-07	4.8e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.64e-07	4.73e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CA—hematologic cancer	3.6e-07	4.68e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CA—hematologic cancer	3.4e-07	4.41e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—hematologic cancer	3.38e-07	4.39e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	3.37e-07	4.38e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTEN—hematologic cancer	3.15e-07	4.09e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—hematologic cancer	3.02e-07	3.92e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—EP300—hematologic cancer	3e-07	3.9e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—hematologic cancer	2.94e-07	3.83e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—hematologic cancer	2.77e-07	3.61e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—hematologic cancer	2.75e-07	3.58e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.22e-07	2.89e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—hematologic cancer	1.81e-07	2.36e-06	CbGpPWpGaD
